1. Market Research
  2. > Pharmaceutical Market Trends

Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity

  • October 2015
  • 77 pages
  • GBI Research
Report ID: 3428757

Summary

Table of Contents

Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity

Summary

GBI Research’s latest report, "Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity" discusses deal-making trends for a range of deal types, such as Mergers & Acquisitions (M&A) and strategic alliances. It also examines preference by deal type, along with disclosed deal values from 2010 to July 2015, covering start-ups, mid-level players, and big players.

Pharmaceutical companies use deal activity to enhance their research activities, regulatory approach, geographic presence, commercialization, and sales. The increasing development of biologics, especially in oncology, has given a significant boost to activity in recent years. Analysis suggests that while the number of deals in 2015 (until July) was lower than the number of deals in 2014, deal value in 2015 has already exceeded that of 2014. Looking at the entire period, although strategic deals were more numerous, M&A deals had the highest deal value. Partnerships were the most preferred type of deal activity, but saw the lowest deal value. North America led in terms of region, followed by Europe and Asia-Pacific. Key deals covered in this report include the acquisition of Allergen by Actavis, asset transactions between Novartis and GlaxoSmithKline, and the partnership between Pfizer and Merck.

Scope

- Which challenges in the pharmaceutical industry are encouraging deal activity?
- How important is deal activity to the market?
Overview of deal activity from 2010 to 2015 -
- What are the trends for M&A and strategic deals, and what are the key differences between the sectors?
- What was the trend for regional involvement in each year?
- How do variations in terms of therapy area preference affect deal activity?
Detailed analysis of recent deal activity -
- How do announced and completed deals vary?
- How do deals in 2014 and 2015 compare in terms of quarterly volume and value?
- Which regions or therapy areas have encouraged recent deal activity?
- Who are the key players?
Complete analysis of recent M&A deals -
- How do M&A deal types differ in terms of number and value?
- Which regions and therapy areas have been involved in M&A deals since 2013?
- Who are the most important players in M&A deals?
- What was the rationale behind key M&A deals?
Complete analysis of recent strategic alliances -
- What are the different strategic alliance deal types?
- Which key regions and therapy areas have been involved in strategic alliances since 2013?
- Which important molecule types and routes of administration have recently been involved in strategic alliances?
- Who are the key players in strategic alliance deals?
- What was the rationale behind key strategic alliance deals?

Reasons to buy

This report will allow you to -
- Gain an insight into pharmaceutical deal activity via in-depth analysis of the current pharmaceutical industry, along with a focus on the most lucrative regions and therapy areas for both M&A and strategic deals
- Examine detailed analysis of key players, covering companies involved in M&A and strategic alliance deals, important deal activity for all deal types, and deals involving companies with the most numerous and highest-value deals.
- Understand how the current deals market is changing, using analysis of deals by molecule type, route of administration, and stage of development.
- Determine the most appropriate deal activity for overcoming challenges and enhancing performance, including detailed analysis of the rationale behind key recent deals.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Clinical Chemistry Reagents and Analyzers Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 75000
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. Please contact Client Services at reports@vpgcorp.com or +1 212 564 ...

Immunodiagnostics Analyzers and Reagents Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 75000
  • Industry report
  • July 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

Cancer Diagnostics Market 2021: A 74-Country Analysis--Supplier Shares and Strategies, Emerging Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 52400
  • Industry report
  • May 2017
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.